BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner R, Peterhoff D, Beileke S, Günther F, Berr M, Einhauser S, Schütz A, Niller HH, Steininger P, Knöll A, Tenbusch M, Maier C, Korn K, Stark KJ, Gessner A, Burkhardt R, Kabesch M, Schedl H, Küchenhoff H, Pfahlberg AB, Heid IM, Gefeller O, Überla K. Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020. Viruses 2021;13:1118. [PMID: 34200766 DOI: 10.3390/v13061118] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Einhauser S, Peterhoff D, Beileke S, Günther F, Niller HH, Steininger P, Knöll A, Korn K, Berr M, Schütz A, Wiegrebe S, Stark KJ, Gessner A, Burkhardt R, Kabesch M, Schedl H, Küchenhoff H, Pfahlberg AB, Heid IM, Gefeller O, Überla K, Wagner R. Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County-Results from a Population-Based Longitudinal Study in Germany. Viruses 2022;14:1168. [PMID: 35746640 DOI: 10.3390/v14061168] [Reference Citation Analysis]
2 Balck A, Föh B, Borsche M, Rahmöller J, Vollstedt EJ, Waldeck F, Käding N, Twesten C, Mischnik A, Gillessen-Kaesbach G, Ehlers M, Sina C, Taube S, Busch H, Rupp J, Katalinic A, Klein C. Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort study. BMC Public Health 2022;22:1305. [PMID: 35799167 DOI: 10.1186/s12889-022-13666-z] [Reference Citation Analysis]
3 Thamm R, Buttmann-Schweiger N, Fiebig J, Poethko-Müller C, Prütz F, Sarganas G, Neuhauser H. [Seroprevalence of SARS-CoV-2 among children and adolescents in Germany-an overview]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021. [PMID: 34731291 DOI: 10.1007/s00103-021-03448-0] [Reference Citation Analysis]
4 Lohse S, Sternjakob-Marthaler A, Lagemann P, Schöpe J, Rissland J, Seiwert N, Pfuhl T, Müllendorff A, Kiefer LS, Vogelgesang M, Vella L, Denk K, Vicari J, Zwick A, Lang I, Weber G, Geisel J, Rech J, Schnabel B, Hauptmann G, Holleczek B, Scheiblauer H, Wagenpfeil S, Smola S. German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance. Commun Med (Lond) 2022;2:52. [PMID: 35603305 DOI: 10.1038/s43856-022-00100-z] [Reference Citation Analysis]
5 Niekrens V, Esse J, Held J, Knobloch CS, Steininger P, Kunz B, Seggewies C, Bogdan C. Homologous COVID-19 BNT162b2 mRNA Vaccination at a German Tertiary Care University Hospital: A Survey-Based Analysis of Reactogenicity, Safety, and Inability to Work among Healthcare Workers. Vaccines 2022;10:650. [DOI: 10.3390/vaccines10050650] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Klein C, Borsche M, Balck A, Föh B, Rahmöller J, Peters E, Knickmann J, Lane M, Vollstedt EJ, Elsner SA, Käding N, Hauswaldt S, Lange T, Hundt JE, Lehrian S, Giese J, Mischnik A, Niemann S, Maurer F, Homolka S, Paulowski L, Kramer J, Twesten C, Sina C, Gillessen-Kaesbach G, Busch H, Ehlers M, Taube S, Rupp J, Katalinic A. One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk. Sci Adv 2022;8:eabm5016. [PMID: 35427158 DOI: 10.1126/sciadv.abm5016] [Reference Citation Analysis]
7 Radev ST, Graw F, Chen S, Mutters NT, Eichel VM, Bärnighausen T, Köthe U. OutbreakFlow: Model-based Bayesian inference of disease outbreak dynamics with invertible neural networks and its application to the COVID-19 pandemics in Germany. PLoS Comput Biol 2021;17:e1009472. [PMID: 34695111 DOI: 10.1371/journal.pcbi.1009472] [Reference Citation Analysis]
8 Peterhoff D, Einhauser S, Beileke S, Niller H, Günther F, Schachtner M, Asbach B, Steininger P, Tenbusch M, Peter AS, Gessner A, Burkhardt R, Heid IM, Wagner R, Überla K. Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants. Vaccines 2022;10:324. [DOI: 10.3390/vaccines10020324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wachtler B, Müters S, Michalski N, Koschollek C, Albrecht S, Haller S, Hamouda O, Hövener C, Hoebel J. Socioeconomic inequalities in the prevalence and perceived dangerousness of SARS-CoV-2 infections in two early German hotspots: findings from a seroepidemiological study. BMC Res Notes 2021;14:375. [PMID: 34565448 DOI: 10.1186/s13104-021-05784-5] [Reference Citation Analysis]
10 Einhauser S, Peterhoff D, Niller HH, Beileke S, Günther F, Steininger P, Burkhardt R, Heid IM, Pfahlberg AB, Überla K, Gefeller O, Wagner R. Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests-A Population-Based Evaluation. Diagnostics (Basel) 2021;11:1843. [PMID: 34679541 DOI: 10.3390/diagnostics11101843] [Reference Citation Analysis]
11 Brandl C, Zimmermann ME, Günther F, Dietl A, Küchenhoff H, Loss J, Stark KJ, Heid IM. Changes in healthcare seeking and lifestyle in old aged individuals during COVID-19 lockdown in Germany: the population-based AugUR study. BMC Geriatr 2022;22:34. [PMID: 34998375 DOI: 10.1186/s12877-021-02677-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]